4//SEC Filing
BRODIE STEVEN G. 4
Accession 0001077183-18-000095
CIK 0001077183other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 6:36 PM ET
Size
12.3 KB
Accession
0001077183-18-000095
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2018-10-22$3.45/sh+13,334$46,002→ 45,953 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-10-22−13,334→ 0 totalExercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (13,334 underlying)
Holdings
- 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 50,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (50,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 58,000
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (58,000 underlying)
Footnotes (4)
- [F1]On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F2]On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F4]On February 26, 2018, Dr. Brodie was granted 58,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001640522
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 6:36 PM ET
- Size
- 12.3 KB